US Stock MarketDetailed Quotes

BioNexus Gene Lab (BGLC)

Watchlist

2.390
+0.280+13.27%

Trading Jun 12 15:44 ET

5.78MMarket Cap-1.61P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioNexus Gene Lab (BGLC) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

-98.93%22.84K

-21.93%7.42M

-80.83%483.76K

-3.29%2.54M

14.47%2.26M

-10.28%2.14M

-2.66%9.51M

11.03%2.52M

3.00%2.63M

-23.07%1.97M

Operating revenue

-98.93%22.84K

-21.93%7.42M

-80.83%483.76K

-3.29%2.54M

14.47%2.26M

-10.28%2.14M

-2.66%9.51M

11.03%2.52M

3.00%2.63M

-23.07%1.97M

Cost of revenue

-98.68%23.63K

-22.89%6.34M

-77.98%487.74K

-5.98%2.17M

12.24%1.89M

-11.07%1.79M

-2.61%8.22M

10.37%2.21M

4.75%2.3M

-24.30%1.69M

Gross profit

-100.23%-790

-15.84%1.09M

-101.29%-3.98K

15.66%377.69K

27.47%368.02K

-5.90%343.49K

-3.01%1.29M

16.01%309.23K

-7.84%326.54K

-15.01%288.72K

Operating expense

-40.54%570.64K

30.72%4.24M

40.27%1.03M

-33.73%1.19M

607.96%1.07M

68.41%959.68K

-26.37%3.25M

48.10%732.87K

-37.81%1.79M

-75.35%150.86K

Selling and administrative expenses

-59.21%380.4K

1.55%4.07M

26.16%1.01M

-51.06%997.26K

61.83%1.13M

98.56%932.57K

31.74%4M

157.83%801.8K

-33.88%2.04M

-13.85%695.32K

-Selling and marketing expense

-90.25%52.73K

-14.50%1.74M

-92.80%35.64K

-55.71%551.57K

345.75%608.43K

251.39%540.7K

240.23%2.03M

--494.86K

--1.25M

--136.49K

-General and administrative expense

-16.38%327.67K

18.05%2.33M

217.94%975.87K

-43.76%445.69K

-7.52%516.79K

24.09%391.88K

-19.19%1.97M

115.48%306.93K

-74.29%792.41K

-30.76%558.83K

Research and development costs

19.34%14.49K

6.65%50.67K

-36.20%11.1K

42.46%14.88K

53.17%12.56K

5.79%12.14K

-13.59%47.51K

--17.4K

--10.44K

--8.2K

Provision for doubtful accounts

1,073.96%175.75K

115.69%126.44K

106.27%5.41K

168.78%175.82K

87.38%-69.76K

-83.12%14.97K

-161.31%-805.88K

---86.32K

---255.61K

---552.66K

Other operating expenses

----

-133.60%-465.53K

-274.10%-730.11K

Operating profit

7.26%-571.43K

-61.41%-3.16M

-143.61%-1.03M

44.74%-810.27K

-607.75%-699.99K

-200.83%-616.19K

36.46%-1.96M

-85.58%-423.64K

42.01%-1.47M

150.65%137.86K

Net non-operating interest income expense

-24.47%14.09K

-49.13%64.35K

-76.85%6.5K

-50.41%14.3K

-45.01%24.89K

-23.28%18.66K

131.06%126.5K

-56.45%28.09K

776.90%28.83K

1,587.80%45.26K

Non-operating interest income

-27.11%17.18K

-43.18%83.89K

-71.17%9.77K

-40.67%20.78K

-40.15%29.77K

-18.68%23.57K

114.99%147.64K

--33.9K

--35.02K

--49.74K

Non-operating interest expense

-37.16%3.09K

-7.59%19.54K

-43.70%3.27K

4.67%6.48K

8.91%4.88K

5.32%4.91K

51.81%21.15K

38.94%5.81K

45.41%6.19K

47.27%4.48K

Other net income (expense)

153.35%13.76K

-53.49%109.5K

59.90%-10.62K

-6.99%86.98K

-17.65%58.93K

-126.65%-25.8K

-43.59%235.42K

-26.48K

93.52K

71.57K

Gain on sale of security

110.20%5.62K

-71.59%50.01K

337.87%77.13K

-7.59%46.57K

-135.57%-18.63K

-198.98%-55.05K

-53.10%176.02K

--17.61K

--50.39K

--52.39K

Earnings from equity interest

----

9.15%-51K

-54.63%-68.5K

----

---56.14K

Other non- operating income (expenses)

-72.15%8.15K

0.13%59.49K

-98.99%-87.75K

-6.29%40.41K

304.56%77.57K

-29.00%29.25K

41.13%59.41K

---44.1K

--43.13K

--19.17K

Income before tax

12.79%-543.58K

-87.14%-2.98M

-145.51%-1.04M

47.24%-708.99K

-341.93%-616.17K

-644.81%-623.33K

38.84%-1.59M

-266.44%-422.03K

46.94%-1.34M

192.53%254.69K

Income tax

-83.77%3.49K

-34.29%-73.71K

-97.97%1.56K

447.62%55.58K

Net income

12.79%-543.58K

-86.73%-2.98M

-197.46%-1.04M

47.30%-708.99K

-409.47%-616.17K

-500.76%-623.33K

39.20%-1.6M

-212.92%-348.32K

48.44%-1.35M

176.80%199.1K

Net income continuous Operations

12.79%-543.58K

-86.73%-2.98M

-197.46%-1.04M

47.30%-708.99K

-409.47%-616.17K

-500.76%-623.33K

39.20%-1.6M

-212.92%-348.32K

48.44%-1.35M

176.80%199.1K

Minority interest income

Net income attributable to the parent company

12.79%-543.58K

-86.73%-2.98M

-197.46%-1.04M

47.30%-708.99K

-409.47%-616.17K

-500.76%-623.33K

39.20%-1.6M

-212.92%-348.32K

48.44%-1.35M

176.80%199.1K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

12.79%-543.58K

-86.73%-2.98M

-197.46%-1.04M

47.30%-708.99K

-409.47%-616.17K

-500.76%-623.33K

39.20%-1.6M

-212.92%-348.32K

48.44%-1.35M

176.80%199.1K

Basic earnings per share

35.16%-0.225

-79.15%-1.607

-170.47%-0.522

47.26%-0.395

-403.54%-0.343

-478.33%-0.347

45.96%-0.897

-172.52%-0.193

51.85%-0.749

163.10%0.113

Diluted earnings per share

35.16%-0.225

-79.15%-1.607

-170.47%-0.522

47.26%-0.395

-403.54%-0.343

-478.33%-0.347

45.96%-0.897

-210.54%-0.193

51.85%-0.749

163.10%0.113

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	-98.93%22.84K	-21.93%7.42M	-80.83%483.76K	-3.29%2.54M	14.47%2.26M	-10.28%2.14M	-2.66%9.51M	11.03%2.52M	3.00%2.63M	-23.07%1.97M
Operating revenue	-98.93%22.84K	-21.93%7.42M	-80.83%483.76K	-3.29%2.54M	14.47%2.26M	-10.28%2.14M	-2.66%9.51M	11.03%2.52M	3.00%2.63M	-23.07%1.97M
Cost of revenue	-98.68%23.63K	-22.89%6.34M	-77.98%487.74K	-5.98%2.17M	12.24%1.89M	-11.07%1.79M	-2.61%8.22M	10.37%2.21M	4.75%2.3M	-24.30%1.69M
Gross profit	-100.23%-790	-15.84%1.09M	-101.29%-3.98K	15.66%377.69K	27.47%368.02K	-5.90%343.49K	-3.01%1.29M	16.01%309.23K	-7.84%326.54K	-15.01%288.72K
Operating expense	-40.54%570.64K	30.72%4.24M	40.27%1.03M	-33.73%1.19M	607.96%1.07M	68.41%959.68K	-26.37%3.25M	48.10%732.87K	-37.81%1.79M	-75.35%150.86K
Selling and administrative expenses	-59.21%380.4K	1.55%4.07M	26.16%1.01M	-51.06%997.26K	61.83%1.13M	98.56%932.57K	31.74%4M	157.83%801.8K	-33.88%2.04M	-13.85%695.32K
-Selling and marketing expense	-90.25%52.73K	-14.50%1.74M	-92.80%35.64K	-55.71%551.57K	345.75%608.43K	251.39%540.7K	240.23%2.03M	--494.86K	--1.25M	--136.49K
-General and administrative expense	-16.38%327.67K	18.05%2.33M	217.94%975.87K	-43.76%445.69K	-7.52%516.79K	24.09%391.88K	-19.19%1.97M	115.48%306.93K	-74.29%792.41K	-30.76%558.83K
Research and development costs	19.34%14.49K	6.65%50.67K	-36.20%11.1K	42.46%14.88K	53.17%12.56K	5.79%12.14K	-13.59%47.51K	--17.4K	--10.44K	--8.2K
Provision for doubtful accounts	1,073.96%175.75K	115.69%126.44K	106.27%5.41K	168.78%175.82K	87.38%-69.76K	-83.12%14.97K	-161.31%-805.88K	---86.32K	---255.61K	---552.66K
Other operating expenses	----	----	----	----	----	----	----	----	-133.60%-465.53K	-274.10%-730.11K
Operating profit	7.26%-571.43K	-61.41%-3.16M	-143.61%-1.03M	44.74%-810.27K	-607.75%-699.99K	-200.83%-616.19K	36.46%-1.96M	-85.58%-423.64K	42.01%-1.47M	150.65%137.86K
Net non-operating interest income expense	-24.47%14.09K	-49.13%64.35K	-76.85%6.5K	-50.41%14.3K	-45.01%24.89K	-23.28%18.66K	131.06%126.5K	-56.45%28.09K	776.90%28.83K	1,587.80%45.26K
Non-operating interest income	-27.11%17.18K	-43.18%83.89K	-71.17%9.77K	-40.67%20.78K	-40.15%29.77K	-18.68%23.57K	114.99%147.64K	--33.9K	--35.02K	--49.74K
Non-operating interest expense	-37.16%3.09K	-7.59%19.54K	-43.70%3.27K	4.67%6.48K	8.91%4.88K	5.32%4.91K	51.81%21.15K	38.94%5.81K	45.41%6.19K	47.27%4.48K
Other net income (expense)	153.35%13.76K	-53.49%109.5K	59.90%-10.62K	-6.99%86.98K	-17.65%58.93K	-126.65%-25.8K	-43.59%235.42K	-26.48K	93.52K	71.57K
Gain on sale of security	110.20%5.62K	-71.59%50.01K	337.87%77.13K	-7.59%46.57K	-135.57%-18.63K	-198.98%-55.05K	-53.10%176.02K	--17.61K	--50.39K	--52.39K
Earnings from equity interest	----	----	----	----	9.15%-51K	-54.63%-68.5K	----	----	----	---56.14K
Other non- operating income (expenses)	-72.15%8.15K	0.13%59.49K	-98.99%-87.75K	-6.29%40.41K	304.56%77.57K	-29.00%29.25K	41.13%59.41K	---44.1K	--43.13K	--19.17K
Income before tax	12.79%-543.58K	-87.14%-2.98M	-145.51%-1.04M	47.24%-708.99K	-341.93%-616.17K	-644.81%-623.33K	38.84%-1.59M	-266.44%-422.03K	46.94%-1.34M	192.53%254.69K
Income tax		0	0	0	0	0	-83.77%3.49K	-34.29%-73.71K	-97.97%1.56K	447.62%55.58K
Net income	12.79%-543.58K	-86.73%-2.98M	-197.46%-1.04M	47.30%-708.99K	-409.47%-616.17K	-500.76%-623.33K	39.20%-1.6M	-212.92%-348.32K	48.44%-1.35M	176.80%199.1K
Net income continuous Operations	12.79%-543.58K	-86.73%-2.98M	-197.46%-1.04M	47.30%-708.99K	-409.47%-616.17K	-500.76%-623.33K	39.20%-1.6M	-212.92%-348.32K	48.44%-1.35M	176.80%199.1K
Minority interest income
Net income attributable to the parent company	12.79%-543.58K	-86.73%-2.98M	-197.46%-1.04M	47.30%-708.99K	-409.47%-616.17K	-500.76%-623.33K	39.20%-1.6M	-212.92%-348.32K	48.44%-1.35M	176.80%199.1K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	12.79%-543.58K	-86.73%-2.98M	-197.46%-1.04M	47.30%-708.99K	-409.47%-616.17K	-500.76%-623.33K	39.20%-1.6M	-212.92%-348.32K	48.44%-1.35M	176.80%199.1K
Basic earnings per share	35.16%-0.225	-79.15%-1.607	-170.47%-0.522	47.26%-0.395	-403.54%-0.343	-478.33%-0.347	45.96%-0.897	-172.52%-0.193	51.85%-0.749	163.10%0.113
Diluted earnings per share	35.16%-0.225	-79.15%-1.607	-170.47%-0.522	47.26%-0.395	-403.54%-0.343	-478.33%-0.347	45.96%-0.897	-210.54%-0.193	51.85%-0.749	163.10%0.113
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm